Abstract
BackgroundThe radiation-induced lung injury is a common complication from radiotherapy in lung cancer. CpG ODN is TLR9 activator with potential immune modulatory effects and sensitization of radiotherapy in lung cancer. This study aimed to examine the effect of CpG ODN on acute radiation-induced lung injury in mice.Methods and resultsThe mouse model of radiation-induced lung injury was established by a single dose of 20 Gy X-rays exposure to the left lung. The results showed that the pneumonia score was lower in RT+CpG group than in RT group on 15th and 30th days. Compared with RT group, CpG ODN reduced the serum concentrations of MDA (P < 0.05) and increased the serum concentrations of SOD, GSH (P < 0.05). The serum concentration of TNF-α in RT+CpG group was lower on 15th and 30th days post-irradiation (P < 0.05).ConclusionThe study demonstrated that CpG ODN has preventive effects of acute radiation-induced lung injury in mice. Lung inflammatory reaction and oxidative stress are promoted in the initiation of radiation-induced pneumonia. CpG ODN may reduce the injury of reactive oxygen species and adjust the serum TNF-α concentration in the mice after irradiation, which reduces the generation of the inflammatory cytokines.
Highlights
The radiation-induced lung injury is a common complication from radiotherapy in lung cancer
Lung inflammatory reaction and oxidative stress are promoted in the initiation of radiation-induced pneumonia
CpG ODN may reduce the injury of reactive oxygen species and adjust the serum tumor necrosis factor-α (TNF-α) concentration in the mice after irradiation, which reduces the generation of the inflammatory cytokines
Summary
The radiation-induced lung injury is a common complication from radiotherapy in lung cancer. CpG ODN is TLR9 activator with potential immune modulatory effects and sensitization of radiotherapy in lung cancer. This study aimed to examine the effect of CpG ODN on acute radiation-induced lung injury in mice. Radiation therapy is one of the most important treatments for the chest tumors, but common complications from such treatments include radiation-induced lung injuries and dose-limiting side effects [1]. Cytosine– phosphate–guanine oligodeoxynucleotides (CpG ODNs) are synthetic DNA sequences containing unmethylated cytosine–guanine motifs, which are identified by activating Toll-like receptor 9 (TLR9) in antigen-presenting cells and B cells. CpG ODN can activate the active immune cells to produce a variety of cytokines which enhance the body’s specific and nonspecific immune effect and prevent a potential microbial infection [2]. It has been proven that CpG ODN can treat infectious diseases, cancer and allergic diseases [3], and has
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
